Sen. Markwayne Mullin Sells Off Shares of Zoetis Inc. (NYSE:ZTS)

Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Zoetis Inc. (NYSE:ZTS). In a filing disclosed on May 12th, the Senator disclosed that they had sold between $15,001 and $50,000 in Zoetis stock on April 8th.

Senator Markwayne Mullin also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Texas Instruments (NASDAQ:TXN) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of CSX (NASDAQ:CSX) on 4/8/2025.
• Sold $50,001 – $100,000 in shares of Lam Research (NASDAQ:LRCX) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of Chevron (NYSE:CVX) on 4/8/2025.
• Sold $50,001 – $100,000 in shares of Thermo Fisher Scientific (NYSE:TMO) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of ConocoPhillips (NYSE:COP) on 4/8/2025.
• Sold $50,001 – $100,000 in shares of Applied Materials (NASDAQ:AMAT) on 4/8/2025.
• Sold $15,001 – $50,000 in shares of Adobe (NASDAQ:ADBE) on 4/8/2025.
• Sold $50,001 – $100,000 in shares of Valero Energy (NYSE:VLO) on 4/8/2025.
• Purchased $15,001 – $50,000 in shares of Capital One Financial (NYSE:COF) on 3/19/2025.

Zoetis Price Performance

NYSE:ZTS opened at $154.77 on Thursday. Zoetis Inc. has a 52 week low of $139.70 and a 52 week high of $200.33. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. The company has a market capitalization of $68.90 billion, a P/E ratio of 28.29, a P/E/G ratio of 2.78 and a beta of 0.94. The stock’s fifty day moving average is $156.72 and its two-hundred day moving average is $165.71.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.20 billion. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The company’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.38 EPS. Equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Insiders Place Their Bets

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the sale, the executive vice president now directly owns 15,781 shares of the company’s stock, valued at approximately $2,682,770. This trade represents a 2.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total value of $201,029.40. Following the sale, the director now directly owns 11,245 shares of the company’s stock, valued at $1,868,244.30. The trade was a 9.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.16% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on ZTS shares. Stifel Nicolaus cut their price target on Zoetis from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Monday, April 14th. Morgan Stanley cut their price target on Zoetis from $243.00 to $238.00 and set an “overweight” rating on the stock in a report on Friday, February 14th. UBS Group cut their price target on Zoetis from $189.00 to $170.00 and set a “neutral” rating on the stock in a report on Wednesday, May 7th. StockNews.com upgraded Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Finally, Barclays upped their price objective on Zoetis from $242.00 to $244.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $212.75.

Institutional Trading of Zoetis

A number of large investors have recently made changes to their positions in the company. Mission Wealth Management LP boosted its position in shares of Zoetis by 2.0% in the 4th quarter. Mission Wealth Management LP now owns 2,938 shares of the company’s stock valued at $479,000 after purchasing an additional 59 shares during the period. VeraBank N.A. boosted its position in shares of Zoetis by 4.1% in the 4th quarter. VeraBank N.A. now owns 1,562 shares of the company’s stock valued at $254,000 after purchasing an additional 62 shares during the period. HUB Investment Partners LLC boosted its position in shares of Zoetis by 4.7% in the 4th quarter. HUB Investment Partners LLC now owns 1,373 shares of the company’s stock valued at $224,000 after purchasing an additional 62 shares during the period. Procyon Advisors LLC boosted its position in shares of Zoetis by 1.4% in the 4th quarter. Procyon Advisors LLC now owns 4,712 shares of the company’s stock valued at $768,000 after purchasing an additional 63 shares during the period. Finally, Coppell Advisory Solutions LLC lifted its position in Zoetis by 18.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 420 shares of the company’s stock worth $68,000 after acquiring an additional 64 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.